Ligand validation:9IKH

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IKH_LFA_N_609	29%	86%	0.203	0.915	0.33	0.38	-	-	6	0	70%	0.6
9IKH_LFA_C_309	28%	96%	0.206	0.876	0.23	0.13	-	-	1	0	90%	0.4
9IKH_LFA_P_313	26%	90%	0.195	0.88	0.4	0.21	-	-	2	0	75%	0.6
9IKH_LFA_P_310	21%	94%	0.254	0.88	0.26	0.19	-	-	2	0	90%	0.4
9IKH_LFA_A_608	18%	88%	0.237	0.882	0.45	0.22	-	-	4	0	70%	0.6
9IKH_LFA_B_307	14%	91%	0.295	0.871	0.39	0.19	-	-	2	0	85%	0.6
9IKH_LFA_A_609	13%	77%	0.263	0.864	0.62	0.32	-	-	6	0	70%	0.6
9IKH_LFA_C_307	13%	96%	0.261	0.883	0.22	0.16	-	-	0	0	55%	0.4
9IKH_LFA_P_314	12%	88%	0.261	0.86	0.31	0.36	-	-	1	0	65%	0.6
9IKH_LFA_P_301	10%	95%	0.304	0.859	0.3	0.12	-	-	0	0	75%	0.4
9IKH_LFA_G_103	10%	72%	0.283	0.844	0.64	0.44	-	-	4	0	70%	0.6
9IKH_LFA_C_313	9%	78%	0.271	0.813	0.42	0.48	-	-	1	0	75%	0.6
9IKH_LFA_O_302	9%	91%	0.317	0.837	0.32	0.24	-	-	2	0	85%	0.6
9IKH_LFA_T_103	9%	95%	0.296	0.867	0.22	0.19	-	-	0	0	55%	0.6
9IKH_LFA_C_310	9%	96%	0.299	0.87	0.17	0.17	-	-	0	0	55%	0.5
9IKH_LFA_T_102	8%	94%	0.342	0.867	0.22	0.21	-	-	0	0	70%	0.5
9IKH_LFA_P_308	7%	91%	0.312	0.858	0.31	0.28	-	-	2	0	55%	0.4
9IKH_LFA_C_312	7%	90%	0.284	0.826	0.32	0.3	-	-	2	0	55%	0.5
9IKH_LFA_P_312	7%	91%	0.297	0.829	0.23	0.33	-	-	1	0	55%	0.5
9IKH_LFA_C_314	6%	93%	0.306	0.813	0.27	0.22	-	-	0	0	65%	0.6
9IKH_LFA_O_303	5%	94%	0.322	0.824	0.28	0.17	-	-	3	0	55%	0.6
9IKH_LFA_P_309	5%	96%	0.326	0.868	0.29	0.09	-	-	0	0	30%	0.4
9IKH_LFA_C_325	5%	97%	0.383	0.827	0.19	0.14	-	-	0	0	75%	0.4
9IKH_LFA_C_311	4%	95%	0.36	0.807	0.27	0.14	-	-	0	0	70%	0.5
9IKH_LFA_C_308	2%	98%	0.407	0.794	0.18	0.11	-	-	0	0	30%	0.4
9IKH_LFA_P_311	1%	95%	0.434	0.734	0.23	0.19	-	-	0	0	55%	0.5
9IKI_LFA_N_608	41%	91%	0.169	0.937	0.29	0.29	-	-	5	0	70%	0.6
9IKG_LFA_P_313	33%	92%	0.187	0.912	0.27	0.24	-	-	0	0	75%	0.6
9KUM_LFA_P_313	32%	90%	0.187	0.908	0.38	0.22	-	-	1	0	75%	0.6
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.4
9KUK_LFA_P_314	30%	86%	0.19	0.896	0.46	0.26	-	-	3	0	75%	0.6
9I6I_LFA_D_313	67%	69%	0.117	0.953	0.3	0.86	-	-	0	0	85%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
9I6H_LFA_C_309	61%	69%	0.136	0.926	0.29	0.88	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.